The BPC-157 administration guide covers dosing and delivery methods
Primary Peptides for Disease Reversal Retatrutide The next generation of metabolic peptides, Retatrutide is a triple agonist (GLP-1, GIP, and glucagon receptor) that produces profound metabolic effects including significant fat loss, improved insulin sensitivity, and enhanced energy expenditure
About 60% of GLP-1 users who experience gastrointestinal side effects report that nighttime injection significantly reduces their perception of nausea, simply because they sleep through the worst of it
Vitamin C is a water-soluble vitamin and antioxidant that plays an important role in many normal physiologic processes in the body
Begin with small portions of fermentable foods like garlic, onion, lentils, or green banana flour
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
